Caseware UK (AP4) 2024.0.164 2024.0.164 2024-09-302024-09-3002023-10-01falseThe principal activity of the company was that of the manufacture and distribution of healthcare products.0falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 14345489 2023-10-01 2024-09-30 14345489 2022-09-08 2023-09-30 14345489 2024-09-30 14345489 2023-09-30 14345489 c:Director2 2023-10-01 2024-09-30 14345489 d:OfficeEquipment 2023-10-01 2024-09-30 14345489 d:OfficeEquipment 2024-09-30 14345489 d:OfficeEquipment 2023-09-30 14345489 d:OfficeEquipment d:OwnedOrFreeholdAssets 2023-10-01 2024-09-30 14345489 d:CurrentFinancialInstruments 2024-09-30 14345489 d:CurrentFinancialInstruments 2023-09-30 14345489 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 14345489 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 14345489 d:ShareCapital 2024-09-30 14345489 d:ShareCapital 2023-09-30 14345489 d:SharePremium 2024-09-30 14345489 d:SharePremium 2023-09-30 14345489 d:RetainedEarningsAccumulatedLosses 2024-09-30 14345489 d:RetainedEarningsAccumulatedLosses 2023-09-30 14345489 c:OrdinaryShareClass1 2023-10-01 2024-09-30 14345489 c:OrdinaryShareClass1 2024-09-30 14345489 c:OrdinaryShareClass1 2023-09-30 14345489 c:FRS102 2023-10-01 2024-09-30 14345489 c:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 14345489 c:FullAccounts 2023-10-01 2024-09-30 14345489 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 14345489 e:PoundSterling 2023-10-01 2024-09-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 14345489









THERA NORDIC UK LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2024

 
THERA NORDIC UK LIMITED
REGISTERED NUMBER: 14345489

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

FIXED ASSETS
  

Tangible assets
 4 
456
-

  
456
-

CURRENT ASSETS
  

Stocks
  
77,789
46,253

Debtors: amounts falling due within one year
 5 
17,370
63,429

Cash at bank and in hand
  
27,053
23,055

  
122,212
132,737

Creditors: amounts falling due within one year
 6 
(148,052)
(130,796)

NET CURRENT (LIABILITIES)/ASSETS
  
 
 
(25,840)
 
 
1,941

TOTAL ASSETS LESS CURRENT LIABILITIES
  
(25,384)
1,941

  

NET (LIABILITIES)/ASSETS
  
(25,384)
1,941


CAPITAL AND RESERVES
  

Called up share capital 
 7 
2
2

Share premium account
  
39,999
39,999

Profit and loss account
  
(65,385)
(38,060)

  
(25,384)
1,941


Page 1

 
THERA NORDIC UK LIMITED
REGISTERED NUMBER: 14345489
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J Laiho
Director

Date: 5 June 2025

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
THERA NORDIC UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


GENERAL INFORMATION

Thera Nordic UK Limited is a private company limited by shares and incorporated in England and Wales. Its registered office address is 51 Casterton Road, Stamford, PE9 2UA.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

GOING CONCERN

Although the Company made a loss during the period, the directors have a reasonable expectation that the Company will continue to receive financial support from its shareholders and directors and therefore has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements continue to be prepared on a going concern basis.

 
2.3

FOREIGN CURRENCY TRANSLATION

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Profit and Loss Account within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
THERA NORDIC UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.ACCOUNTING POLICIES (CONTINUED)

 
2.4

TURNOVER

Turnover comprises the fair value of the consideration recieved or receivable for the sale of goods and provision of services in the ordinary course of the Company's activities. Turnover is shown net of value added tax, returns, rebates and discounts.

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.5

FINANCE COSTS

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

STOCKS

Stocks are measured at the lower of cost and estimated selling prices less costs to complete and
sell. Cost includes all costs of purchase, cost of conversion and other costs incurred in bringing the
stocks to their present location and condition.

Page 4

 
THERA NORDIC UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.ACCOUNTING POLICIES (CONTINUED)

 
2.8

DEBTORS

Short-term debtors are measured at transaction price, less any impairment.

 
2.9

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

CREDITORS

Short-term creditors are measured at the transaction price.

 
2.11

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.



3.


EMPLOYEES




The Company has no employees other than the directors, who did not receive any remuneration (2023 - £NIL).



Page 5

 
THERA NORDIC UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4.


TANGIBLE FIXED ASSETS





Office equipment

£



COST OR VALUATION


Additions
531



At 30 September 2024

531



DEPRECIATION


Charge for the year on owned assets
75



At 30 September 2024

75



NET BOOK VALUE



At 30 September 2024
456



At 30 September 2023
-

Page 6

 
THERA NORDIC UK LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

5.


DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024
2023
£
£


Trade debtors
2,707
3,079

Other debtors
1
9,148

Prepayments and accrued income
14,662
51,202

17,370
63,429



6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024
2023
£
£

Trade creditors
31,234
26,461

Other taxation and social security
3,034
-

Other creditors
106,375
102,535

Accruals and deferred income
7,409
1,800

148,052
130,796


Other creditors includes a loan from a director that is repayable on demand. Interest is charged at a rate of 12.5% per annum.


7.


SHARE CAPITAL

2024
2023
£
£
ALLOTTED, CALLED UP AND FULLY PAID



2,000,000 (2023 - 1,666,767) Ordinary shares of £0.000001 each
2
2

On 2 October 2023, the Company issued a further 333,333 Ordinary shares of £0.000001 each.


 
Page 7